These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2839975)

  • 21. Congestive heart failure: an unusual presentation of pseudohypoparathyroidism.
    Cho MJ; Ban KH; Park JA; Lee HD
    Pediatr Emerg Care; 2013 Jul; 29(7):826-8. PubMed ID: 23823262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transitory pseudohypoparathyroidism in the newborn infant].
    Schaumberger E; Hohenauer L; Sommer R
    Klin Padiatr; 1986; 198(4):349-52. PubMed ID: 3762009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cinacalcet as adjunctive therapy in pseudohypoparathyroidism type 1b.
    Srivastava T; Krudys J; Mardis NJ; Sebestyen-VanSickle J; Alon US
    Pediatr Nephrol; 2016 May; 31(5):795-800. PubMed ID: 26628282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective long-term treatment of pseudohypoparathyroidism with oral 1alpha-hydroxy- and 1,25-dihydroxy-cholecalciferol.
    Werder EA; Kind HP; Egert F; Fischer JA; Prader A
    J Pediatr; 1976 Aug; 89(2):266-8. PubMed ID: 940021
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma levels of parathyroid hormone (1-84) whole molecule and parathyroid hormone (7-84)-like fragments in pseudohypoparathyroidism type I.
    Hatakeyama Y; Mizunashi K; Furukawa Y; Yabuki S; Sato Y; Igarashi T
    J Clin Endocrinol Metab; 2003 May; 88(5):2250-5. PubMed ID: 12727982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism.
    Drezner MK; Neelon FA; Haussler M; McPherson HT; Lebovitz HE
    J Clin Endocrinol Metab; 1976 Apr; 42(4):621-8. PubMed ID: 1083395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypomagnesemia masking the appearance of elevated parathyroid hormone concentrations in familial pseudohypoparathyroidism.
    Allen DB; Friedman AL; Greer FR; Chesney RW
    Am J Med Genet; 1988 Sep; 31(1):153-8. PubMed ID: 3223496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of pseudohypoparathyroidism with frequent normocalcemia (author's transl)].
    Yumita S; Unakami H; Sohn HW; Furukawa Y
    Nihon Naibunpi Gakkai Zasshi; 1981 Sep; 57(9):1239-46. PubMed ID: 6274713
    [No Abstract]   [Full Text] [Related]  

  • 29. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract.
    Werder EA; Fischer JA; Illig R; Kind HP; Bernasconi S; Fanconi A; Prader A
    J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma.
    Seymour JF; Gagel RF; Hagemeister FB; Dimopoulos MA; Cabanillas F
    Ann Intern Med; 1994 Nov; 121(9):633-40. PubMed ID: 7944070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1,25-Dihydroxyvitamin D production stimulated by dibutyryl 3', 5'-cyclic AMP in normal subjects and a patient with pseudohypoparathyroidism.
    Unakami H; Furukawa Y; Sohn HE; Yumita S; Miura R; Sasaki A; Kokubun M; Miura Y; Yoshinaga K; Nakanome C
    Tohoku J Exp Med; 1982 Dec; 138(4):411-8. PubMed ID: 6298969
    [No Abstract]   [Full Text] [Related]  

  • 32. Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.
    Collins MT; Lindsay JR; Jain A; Kelly MH; Cutler CM; Weinstein LS; Liu J; Fedarko NS; Winer KK
    J Bone Miner Res; 2005 Nov; 20(11):1944-50. PubMed ID: 16234967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone.
    Chase LR; Melson GL; Aurbach GD
    J Clin Invest; 1969 Oct; 48(10):1832-44. PubMed ID: 4309802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal responses to PTH in patients with hormone-resistant (pseudo) hypoparathyroidism.
    Moses AM; Breslau N; Coulson R
    Am J Med; 1976 Aug; 61(2):184-9. PubMed ID: 181985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone tissue and cell dynamics determined by tetracycline labeling in a case of pseudohypoparathyroidism (and in the patient's mother).
    Takahashi H; Frost HM; Kuhn T
    Clin Orthop Relat Res; 1966; 49():163-8. PubMed ID: 5962614
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful off-label use of cinacalcet HCl after standard therapy failure in a young man with pseudohypoparathyroidism Type 1b and vitamin D intoxication sequelae.
    Koch M; Kohnle M
    Clin Nephrol; 2008 Nov; 70(5):439-44. PubMed ID: 19000547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recovery from symptoms in pseudohypoparathyroidism.
    Felitti VJ; McAfee LL
    Johns Hopkins Med J; 1968 Dec; 123(6):271-5. PubMed ID: 5704483
    [No Abstract]   [Full Text] [Related]  

  • 38. Pseudohypoparathyroidism with normal serum calcium level.
    Balachandar V; Pahuja J; Maddaiah VT; Collipp PJ
    Am J Dis Child; 1975 Sep; 129(9):1092-5. PubMed ID: 171942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudohypoparathyroidism with raised plasma alkaline phosphatase.
    Cohen RD; Vince FP
    Arch Dis Child; 1969 Feb; 44(233):96-101. PubMed ID: 5304559
    [No Abstract]   [Full Text] [Related]  

  • 40. Regulation of 1,25 (OH)2D synthesis in hypoparathyroidism and pseudohypoparathyroidism.
    Breslau NA; Weinstock RS
    Am J Physiol; 1988 Nov; 255(5 Pt 1):E730-6. PubMed ID: 2847540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.